Zimmer Biomet To Stop Selling CPT Hip Implant System By End Of 2024 Due To High Fracture Risks
Zimmer Biomet Holdings, Inc (NYSE:ZBH) announced plans to phase out its CPT Hip System by December. The decision comes on the ...
Becker's Spine Review1d
How well-positioned is Zimmer Biomet for 2025?
Zimmer Biomet had a strong 2024, bolstering its product lines and staying on top of orthopedic medtech trends.
Citi opens ‘positive catalyst watch’ on Zimmer Biomet
Citi opened a “90-day positive catalyst watch” on shares of Zimmer Biomet (ZBH) while keeping a Neutral rating on the name with a $120 price ...
Investing16d
FDA approves Zimmer Biomet's cementless knee implant
Upcoming product launches, including the Z1 hip system and Persona IQ knee technology, are expected to drive growth. These are recent developments in the company's performance and strategy. The FDA ...